BRAIDWELL LP
CIK 1920938 · Holdings on Sep 30, 2025 · First reported Nov 14, 2025
Top ten holdings
Q3 2025- 40131MAD18.49%
- CAI6.57%
- NVCR6.23%
- XENE4.29%
- CGON3.92%
- NBIX3.67%
- 759916AD13.02%
- KRYS2.73%
- NUVL2.60%
- 64049MAB62.58%
Share classes counted separately44.10%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- ARGXWeight decreased · -2.00 pp3.67% → 1.67%Shares -118.40K (-60.88%)
- ALGNWeight decreased · -1.70 pp3.22% → 1.52%Shares -87.04K (-17.52%)
- NVCRWeight increased · +1.52 pp4.71% → 6.23%Shares +70.53M (+50.08%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | 40131MAD1GUARDANT HEALTH INCDEBT 1.250% 2/1 View history and evidence | $286.28M | 8.49% | 219.45M principal (USD) | 8.77% → 8.49%-0.28 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | CAICARIS LIFE SCIENCES INC View history and evidence | $221.31M | 6.57% | 7.32M shares | 6.69% → 6.57%-0.12 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | NVCRNOVOCURE LTDNOTE 11/0 View history and evidence | $210.04M | 6.23% | 211.36M principal (USD) | 4.71% → 6.23%+1.52 pp +70.53M (+50.08%) | Added | ↗▾ |
| 04 | XENEXENON PHARMACEUTICALS INC View history and evidence | $144.74M | 4.29% | 3.61M shares | 3.86% → 4.29%+0.43 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | CGONCG ONCOLOGY INC View history and evidence | $132.25M | 3.92% | 3.28M shares | 2.92% → 3.92%+1.00 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | NBIXNEUROCRINE BIOSCIENCES INC View history and evidence | $123.57M | 3.67% | 880.28K shares | 4.99% → 3.67%-1.32 pp -280.14K (-24.14%) | Reduced | ↗▾ |
| 07 | 759916AD1REPLIGEN CORPNOTE 1.000%12/1 View history and evidence | $101.81M | 3.02% | 101.00M principal (USD) | 3.44% → 3.02%-0.42 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | KRYSKRYSTAL BIOTECH INC View history and evidence | $91.87M | 2.73% | 520.40K shares | 3.42% → 2.73%-0.69 pp -207.41K (-28.50%) | Reduced | ↗▾ |
| 09 | NUVLNUVALENT INC-A View history and evidence | $87.60M | 2.60% | 1.01M shares | 3.07% → 2.60%-0.47 pp -162.89K (-13.85%) | Reduced | ↗▾ |
| 10 | 64049MAB6NEOGENOMICS INCNOTE 0.250% 1/1 View history and evidence | $86.83M | 2.58% | 100.38M principal (USD) | 2.98% → 2.58%-0.40 pp -1.00M (-0.99%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 7
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| GH GUARDANT HEALTH INC | Non-derivative | -837,800 | -$43.60M | SEC filing ↗ | SEC filing ↗ |
| APLS APELLIS PHARMACEUTICALS INC | Non-derivative | -1,121,034 | -$19.41M | SEC filing ↗ | SEC filing ↗ |
| MDGL MADRIGAL PHARMACEUTICALS INC | Non-derivative | -60,781 | -$18.39M | SEC filing ↗ | SEC filing ↗ |
3 / 7 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1920938 · Period 2025-09-30
Data loaded 2026-09-23 · First reported 2025-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 3370348920
}Research all 73 reported holdings.
This page includes 30 of 73 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 73 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1920938","quarter":"2025Q3","page_size":100}
get_institutional_manager_history
{"cik":"1920938","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.